Sfoglia per Rivista
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA
2012-01-01 Brusa D; Serra S; Bianco M; Coscia M; Rossi D; Gaidano G; Fedele G; Deaglio S
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia.
2013-01-01 Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S.
Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
2002-01-01 F. MORABITO; M. MANGIOLA; C. STELITANO; S. DEAGLIO; V. CALLEA; F. MALAVASI
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications.
1996-01-01 AGLIETTA M ;DE VINCENTIIS A ;LANATA L ;LANZA F ;LEMOLI RM ;MENICHELLA G ;TAFURI A ;ZANON P ;TURA S
Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia
2001-01-01 Mattei, D; Saglio, G; Gottardi, E; Gallamini, A; Mordini, N; Bacigalupo, A
Personalized medicine in lymphoma: Is it worthwhile? The mantle cell lymphoma experience
2015-01-01 Dreyling, Martin; Ferrero, Simone
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS
2014-01-01 Fava C; Cusato J; Ariaudo A; D'Avolio A; De Francia S; Giugliano E; Rege-Cambrin G; Saglio G
PHASE 3 ALCANZA STUDY OF BRENTUXIMAB VEDOTIN (BV) OR PHYSICIAN'S CHOICE (PC) OF METHOTREXATE (MTX) OR BEXAROTENE (BEX) IN CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA (CTCL): NUMBER NEEDED TO TREAT ANALYSIS
2017-01-01 Zagadailov, E; Prince, HM; Whittaker, S; Horwitz, S; Duvic, M; Kim, Y; Dummer, R; Scarisbrick, J; Quaglino, P; Zinzani, PL; Wolter, P; Geskin, L; Feliciano, J; Wang, Y; Palanca-Wessels, MC; Gautam, A; Zhu, Y; Lin, HM; Liu, Y; Little, M; Dalal, MR
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major
2006-01-01 GALANELLO R; PIGA A; FORNI GL; BERTRAND Y; FOSCHINI ML; BORDONE E ;LEONI G; LAVAGETTO A; ZAPPU A; LONGO F; MASERUKA H; HEWSON N; SECHAUD R; BELLELI R; ALBERTI D
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS
2014-01-01 Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, M; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, M; Tedeschi, A
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients
2015-01-01 Tedeschi, Alessandra; Rossi, Davide; Motta, Marina; Quaresmini, Giulia; Rossi, Marianna; Coscia, Marta; Anastasia, Antonella; Rossini, Fausto; Cortelezzi, Agostino; Nador, Guido; Scarfo, Lydia; Cairoli, Roberto; Frustaci, Anna Maria; Dalceggio, Daniela; Picardi, Paola; de Paoli, Lorenzo; Orlandi, Ester; Rambaldi, Alessandro; Massaia, Massimo; Gaidano, Gianluca; Montillo, Marco
Phenotypic and functional analysis of peripheral blood lymphocytes during interferon-alpha 2b therapy in multiple myeloma patients with low tumor mass
1991-01-01 BIANCHI A; OMEDÈ P; ATTISANO C; CAMPONI A; DIANZANI U; BOCCADORO M; PILERI A; MASSAIA M
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2009-01-01 Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M.
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells.
2012-01-01 Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R.
Plasticità della cellule staminali mesenchimali
2005-01-01 MARESCHI K; NOVARA N; RUSTICHELLI D; GUIDO D; GARBOSSA D; MEREUTA M; CARBONE E; MADON E; VERCELLI A; FAGIOLI F.
Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy.
2003-01-01 VISCOMI S; PASTORE G; MOSSO ML; TERRACINI B; MADON E; MAGNANI C; MERLETTI F
Positive and negative signals in the control of myelopoiesis.
1989-01-01 AGLIETTA M
Post-transplant cyclophosphamide versus antithymocyte-globulin as graft versus host disease prophylaxis in haploidentical transplant
2016-01-01 Ruggeri, Annalisa; Sun, Yuqian; Labopin, Myriam; Bacigalupo, Andrea; Lorentino, Francesca; Arcese, William; Santarone, Stella; Gülbas, Zafar; Blaise, Didier; Messina, Giuseppe; Ghavamzadeh, Ardeshi; Malard, Florent; Bruno, Benedetto; Diez-Martin, Jose Luis; Koc, Yener; Ciceri, Fabio; Mohty, Mohamad; Nagler, Arnon
Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?
2019-01-01 Saglio, Giuseppe; Fava, Carmen; Gale, Robert Peter
Pregnancy and beta-thalassemia: an Italian multicenter experience
2010-01-01 R. Origa; A. Piga; G. Quarta; G. L. Forni; F. Longo; A. Melpignano; R. Galanello
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2012 | Brusa D; Serra S; Bianco M; Coscia M; Rossi D; Gaidano G; Fedele G; Deaglio S | |
| The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia. | 2013 | Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S. | |
| Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. | 2002 | F. MORABITO; M. MANGIOLA; C. STELITANO; S. DEAGLIO; V. CALLEA; F. MALAVASI | |
| Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications. | 1996 | AGLIETTA M ;DE VINCENTIIS A ;LANATA L ;LANZA F ;LEMOLI RM ;MENICHELLA G ;TAFURI A ;ZANON P ;TURA S | |
| Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia | 2001 | Mattei, D; Saglio, G; Gottardi, E; Gallamini, A; Mordini, N; Bacigalupo, A | |
| Personalized medicine in lymphoma: Is it worthwhile? The mantle cell lymphoma experience | 2015 | Dreyling, Martin; Ferrero, Simone | |
| PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS | 2014 | Fava C; Cusato J; Ariaudo A; D'Avolio A; De Francia S; Giugliano E; Rege-Cambrin G; Saglio G | |
| PHASE 3 ALCANZA STUDY OF BRENTUXIMAB VEDOTIN (BV) OR PHYSICIAN'S CHOICE (PC) OF METHOTREXATE (MTX) OR BEXAROTENE (BEX) IN CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA (CTCL): NUMBER NEEDED TO TREAT ANALYSIS | 2017 | Zagadailov, E; Prince, HM; Whittaker, S; Horwitz, S; Duvic, M; Kim, Y; Dummer, R; Scarisbrick, J; Quaglino, P; Zinzani, PL; Wolter, P; Geskin, L; Feliciano, J; Wang, Y; Palanca-Wessels, MC; Gautam, A; Zhu, Y; Lin, HM; Liu, Y; Little, M; Dalal, MR | |
| Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major | 2006 | GALANELLO R; PIGA A; FORNI GL; BERTRAND Y; FOSCHINI ML; BORDONE E ;LEONI G; LAVAGETTO A; ZAPPU A; LONGO F; MASERUKA H; HEWSON N; SECHAUD R; BELLELI R; ALBERTI D | |
| A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS | 2014 | Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, M; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, M; Tedeschi, A | |
| A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients | 2015 | Tedeschi, Alessandra; Rossi, Davide; Motta, Marina; Quaresmini, Giulia; Rossi, Marianna; Coscia, Marta; Anastasia, Antonella; Rossini, Fausto; Cortelezzi, Agostino; Nador, Guido; Scarfo, Lydia; Cairoli, Roberto; Frustaci, Anna Maria; Dalceggio, Daniela; Picardi, Paola; de Paoli, Lorenzo; Orlandi, Ester; Rambaldi, Alessandro; Massaia, Massimo; Gaidano, Gianluca; Montillo, Marco | |
| Phenotypic and functional analysis of peripheral blood lymphocytes during interferon-alpha 2b therapy in multiple myeloma patients with low tumor mass | 1991 | BIANCHI A; OMEDÈ P; ATTISANO C; CAMPONI A; DIANZANI U; BOCCADORO M; PILERI A; MASSAIA M | |
| PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2009 | Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M. | |
| Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. | 2012 | Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R. | |
| Plasticità della cellule staminali mesenchimali | 2005 | MARESCHI K; NOVARA N; RUSTICHELLI D; GUIDO D; GARBOSSA D; MEREUTA M; CARBONE E; MADON E; VERCELLI A; FAGIOLI F. | |
| Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy. | 2003 | VISCOMI S; PASTORE G; MOSSO ML; TERRACINI B; MADON E; MAGNANI C; MERLETTI F | |
| Positive and negative signals in the control of myelopoiesis. | 1989 | AGLIETTA M | |
| Post-transplant cyclophosphamide versus antithymocyte-globulin as graft versus host disease prophylaxis in haploidentical transplant | 2016 | Ruggeri, Annalisa; Sun, Yuqian; Labopin, Myriam; Bacigalupo, Andrea; Lorentino, Francesca; Arcese, William; Santarone, Stella; Gülbas, Zafar; Blaise, Didier; Messina, Giuseppe; Ghavamzadeh, Ardeshi; Malard, Florent; Bruno, Benedetto; Diez-Martin, Jose Luis; Koc, Yener; Ciceri, Fabio; Mohty, Mohamad; Nagler, Arnon | |
| Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia? | 2019 | Saglio, Giuseppe; Fava, Carmen; Gale, Robert Peter | |
| Pregnancy and beta-thalassemia: an Italian multicenter experience | 2010 | R. Origa; A. Piga; G. Quarta; G. L. Forni; F. Longo; A. Melpignano; R. Galanello |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile